PH13858A - Stabilized thymosin fraction 5 and method for preparing same - Google Patents

Stabilized thymosin fraction 5 and method for preparing same

Info

Publication number
PH13858A
PH13858A PH20803A PH20803A PH13858A PH 13858 A PH13858 A PH 13858A PH 20803 A PH20803 A PH 20803A PH 20803 A PH20803 A PH 20803A PH 13858 A PH13858 A PH 13858A
Authority
PH
Philippines
Prior art keywords
thymosin fraction
preparing same
stabilized
reconstitution
permeate
Prior art date
Application number
PH20803A
Other languages
English (en)
Inventor
H Newmark
W Mcgregor
A Ramel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH13858A publication Critical patent/PH13858A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2292Thymosin; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
PH20803A 1977-02-22 1978-02-21 Stabilized thymosin fraction 5 and method for preparing same PH13858A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/770,480 US4082737A (en) 1977-02-22 1977-02-22 Stabilized thymosin composition and method

Publications (1)

Publication Number Publication Date
PH13858A true PH13858A (en) 1980-10-22

Family

ID=25088687

Family Applications (1)

Application Number Title Priority Date Filing Date
PH20803A PH13858A (en) 1977-02-22 1978-02-21 Stabilized thymosin fraction 5 and method for preparing same

Country Status (20)

Country Link
US (1) US4082737A (fr)
JP (1) JPS53104719A (fr)
AT (1) AT363177B (fr)
AU (1) AU516946B2 (fr)
BE (1) BE864139A (fr)
CA (1) CA1099633A (fr)
CH (1) CH632164A5 (fr)
DE (1) DE2807202C2 (fr)
DK (1) DK78378A (fr)
FR (1) FR2380782A1 (fr)
GB (1) GB1546027A (fr)
IE (1) IE46409B1 (fr)
IL (1) IL54063A0 (fr)
IT (1) IT1092337B (fr)
LU (1) LU79090A1 (fr)
NL (1) NL189281C (fr)
NZ (1) NZ186489A (fr)
PH (1) PH13858A (fr)
SE (1) SE444647B (fr)
ZA (1) ZA78890B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732587A1 (de) * 1976-09-22 1978-03-23 Bach Jean Francois Polypeptid mit thymischer wirksamkeit
US4148788A (en) * 1978-01-23 1979-04-10 Hoffmann-La Roche Inc. Synthesis of thymosin α1
US4239498A (en) * 1978-11-27 1980-12-16 Rule Allyn H Method of preparing thymic factors and composition
US4264571A (en) * 1979-01-22 1981-04-28 George Washington University Radioimmunoassay of thymosin α1
WO1982000407A1 (fr) * 1980-08-08 1982-02-18 Sykes A Systeme d'etageres ameliore
US4389343A (en) * 1981-12-24 1983-06-21 Hoffmann-La Roche Inc. Immunopotentiating peptides from thymus
US4388234A (en) * 1981-12-28 1983-06-14 Hoffmann-La Roche Inc. Peptide isolation
US4614731A (en) * 1983-09-15 1986-09-30 Hoffmann-La Roche Inc. Peptide having immunopotentiating activity similar to thymosin alpha1
US4659694A (en) * 1983-10-27 1987-04-21 Hoffmann-La Roche Inc. Prothymosin alpha
US4814434A (en) * 1984-02-03 1989-03-21 Ventres Laboratories, Inc. Inducer of T-suppressor cells
DE3633651A1 (de) * 1986-10-03 1988-04-14 Alfred Dr Dick Verwendung von fraktionen aus thymus- und milzextrakten zur behandlung der psoriasis
US5273963A (en) * 1991-03-29 1993-12-28 The George Washington University Compositions and methods for treating small cell and nonsmall cell lung cancers
JP4404866B2 (ja) 2006-03-03 2010-01-27 ゼライス株式会社 エンドトキシン含有量を低減したゼラチンの製造方法および低エンドトキシンゼラチン

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002602A (en) * 1974-03-11 1977-01-11 Gideon Goldstein Ubiquitous immunopoietic polypeptide (UBIP) and methods
US4010148A (en) * 1975-05-12 1977-03-01 Board Of Regents Of The University Of Texas System Purified thymosin and process
US4002740A (en) * 1975-08-21 1977-01-11 Gideon Goldstein Tridecapeptide compositions and methods

Also Published As

Publication number Publication date
AU516946B2 (en) 1981-07-02
IL54063A0 (en) 1978-04-30
SE7802014L (sv) 1978-08-23
AT363177B (de) 1981-07-10
SE444647B (sv) 1986-04-28
IE46409B1 (en) 1983-06-01
NL7801422A (nl) 1978-08-24
JPS618806B2 (fr) 1986-03-18
ATA124578A (de) 1980-12-15
DK78378A (da) 1978-08-23
ZA78890B (en) 1979-01-31
IT1092337B (it) 1985-07-06
GB1546027A (en) 1979-05-16
IT7819791A0 (it) 1978-01-30
NL189281B (nl) 1992-10-01
NZ186489A (en) 1981-01-23
AU3334378A (en) 1979-08-23
DE2807202A1 (de) 1978-08-24
FR2380782B1 (fr) 1980-01-18
DE2807202C2 (de) 1987-04-02
CH632164A5 (de) 1982-09-30
JPS53104719A (en) 1978-09-12
CA1099633A (fr) 1981-04-21
NL189281C (nl) 1993-03-01
IE780335L (en) 1978-08-22
LU79090A1 (fr) 1979-05-25
FR2380782A1 (fr) 1978-09-15
BE864139A (fr) 1978-08-21
US4082737A (en) 1978-04-04

Similar Documents

Publication Publication Date Title
FR2380782B1 (fr)
SE8402560L (sv) Farmaceutisk komposition
IT8026587A0 (it) Eteri basici, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono.
MX6015E (es) Procedimiento para la preparacion de composiciones de globulina de suero inmune,altamente estabilizada
IT8719389A0 (it) Impiego di derivati delmetilendiossibenzene con funzione sinergizzante in composizioini per uso insetticida.
IT8548348A0 (it) Derivati di amminofenolo,procedimento per prepararli e composizione farmaceutica che li contiene
IT1148435B (it) Perfezionamento nei pannolini monouso per neonati,dotati di nastri di applicazione elasticizzati
MX9207605A (es) Composicion farmaceutica que contiene glucosidos de antraciclina unidos a un derivado polimerico y metodo para preparar la misma.
NO160482C (no) Flytende steriliserings-blanding inneholdende fenoksyetanol, glutaraldehyd, formaldehyd eller glyoksal.
SE413171B (sv) Fergkompositioner for keratinfibrer, i synnerhet for menniskohar, innehallande 3-halogen-6-acetylamino (eller ureido) fenol-kopplingssubstanser
ES505028A0 (es) Sistema indicador perfeccionado para determinar el periodo de utilidad de productos, con liberacion de agentes activos en la atmosfera.
IT8423517A0 (it) Composizione farmaceutica per combattere infezioni virali, eprocedimento di uso per le infezioni virali.
IT1170749B (it) Perfezionamento nei sistemi di infusione per uso medicale
IT8721055A0 (it) Derivati prostaglandinici, procedimenti per prepararli e composizioni farmaceutiche che licontengono.
IT8421310A0 (it) Meccanismo per mobili per sedersi e, rispettivamente per riposarsi.
IT8548819A0 (it) Derivati di imidazopiridazina,composizione farmaceutica che li contiene e procedimento per prepararli
IT8022188A0 (it) Derivati nicotinici di glucosamina, procedimento per la preparazione e relative composizioni farmaceutiche.
Bailey-Cristall Mapleridge: social atmosphere for troubled children
NO913502L (no) Kompositt for anvendelse som hoeyenergi-sprengstoff eller drivmiddel.
FA et al. Influence of combined effects of bleomycin and X-rays on the growth rate of eat and hela cells
IT8021005A0 (it) Dispositivo meccanico per uso implantologico dentale, con moncone orientabile e bloccabile in posizione.
IT8021163A0 (it) Derivati n-pirrolil-piridazinaminici conattivita' anti-ipertensiva, il procedimento per la loro preparazione e il loro uso come agenti anti-ipertensivi.
IT8130821V0 (it) Modulo autoimbustante particolarmente per avvisi da spedire via posta.
ES295861Y (es) Jeringa para inyecciones, especialmente jeringa para inyecciones de un solo uso.
BR6702885U (pt) Modulo para uso determinado,em particular no preparo de alimentos

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 14